In CSF, IGF2 has been identified as a marker of mild cognitive impairment in Alzheimer’s patients [30] and as a biomarker for the progression of amyotrophic lateral sclerosis [31]. Here, IGF2 is linked to amyotrophic lateral sclerosis.